0 avis
Early mortality after implantable cardioverter defibrillator: Incidence and associated factors
Archive ouverte
International audience. Background: According to guidelines, implantable cardioverter defibrillator (ICD) candidates must have a "reasonable expectation of survival with a good functional status >1 year". Identifying risk for early mortality in ICD candidates could be challenging. We aimed to identify factors associated with a =1-year survival among patients implanted with ICDs.Methods: The DAI-PP program was a multicenter, observational French study that included all patients who received a primary prevention ICD in the 2002-2012 period. Characteristics of patients who survived <= 1 year following the implantation were compared with those who survived N1 year, and predictors of early death determined.Results: Out of the 5539 enrolled patients, survival status at 1 yearwas known for a total of 5,457, and overall 230 (4.2%) survived <= 1 year. Causes of deathwere similar in the two groups. Patientswith <= 1-year survival had lower rates of appropriate (14 vs. 23%; P= 0.004) and inappropriate ICD therapies (2 vs. 7%; P = 0.009) than patients who lived N1 year after ICD implantation. In multivariate analysis, older age, higher NYHA class (>= III), and atrial fibrillation were significantly associatedwith <= 1-year survival. Presence of all 3 risk factors was associatedwith a cumulative 22.63% risk of death within 1 year after implantation.Conclusions: This is the largest study determining the factors predicting earlymortality after ICD implantation. Patients dying within the first year had low ICD therapy rates. A combination of clinical factors could potentially identify patients at risk for early mortality to help improve selection of ICD candidates. (C) 2019 Elsevier B.V. All rights reserved.
Consulter en ligne
Suggestions
Du même auteur
